| |
|
Global Hepatitis Summit - Retreatment With Sofosbuvir/Velpatasvir/Voxilaprevir
for 12 Weeks Is Safe and Effective for Patients Who
Have Previously Received Sofosbuvir/Velpatasvir or
Sofosbuvir/Velpatasvir/Voxilaprevir
|
| |
| |
Reported by Jules Levin
Peter Ruane,1 Simone I. Strasser,2 Edward J. Gane,3 Robert H. Hyland,4
Jiang Shao,4 Hadas Dvory-Sobol,4 Tram Tran,4 Luisa M. Stamm,4
Diana M. Brainard,4 Lisa Nyberg,5 Stephen Shafran6
1Ruane Medical & Liver Health Institute, Los Angeles, California, USA;
2AW Morrow Gastroenterology and Liver Centre, Sydney, New South Wales, Australia;
3The University of Auckland, New Zealand; 4Gilead Sciences, Inc., Foster City, California;
5Kaiser Permanente, San Diego, California; 6University of Alberta, Edmonton, Canada
| |
| |
| |
|
|
|
